Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide

Extracranial and meningeal seeding of glioblastoma multiforme is rare. We report herein a case of glioblastoma in a 41-year-old man who underwent surgical resection, concomitant chemoradiotherapy (CCRT) and seven courses of adjuvant chemotherapy with temozolomide. The patient then complained of inte...

Full description

Bibliographic Details
Published in:	Asian Journal of Surgery
Main Authors:	Lu-Ting Kuo, Shao-Yu Tsai, Chung-Yi Yang, Long-Wei Lin
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Subjects:	glioblastoma multiforme meningeal seeding spinal temozolomide
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958413000699

Similar Items

Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review
by: Fateen Ata, et al.
Published: (2021-03-01)

De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells
by: Megan Pitz, et al.
Published: (2022-09-01)

Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes
by: Marcin Jezierzański, et al.
Published: (2024-07-01)

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
by: Jiao Meng, et al.
Published: (2024-03-01)

Molecular Docking and Molecular Dynamics Studies Reveal Secretory Proteins as Novel Targets of Temozolomide in Glioblastoma Multiforme
by: Sumera, et al.
Published: (2022-10-01)

Development of Angiopep-2 targeted dendrimer-based nanotheranostic system for enhanced temozolomide delivery to glioblastoma multiforme
by: Ashish Kumar Parashar, et al.
Published: (2025-02-01)

The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review
by: Ehsan Alimohammadi, et al.
Published: (2020-02-01)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
by: Milan Teraiya, et al.
Published: (2023-04-01)

Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management
by: Brandon Edelbach, et al.
Published: (2024-03-01)

Radiotherapy in Glioblastoma Multiforme: Evolution, Limitations, and Molecularly Guided Future
by: Castalia Fernández, et al.
Published: (2025-09-01)

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01)

Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)

The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
by: Łukasz A. Poniatowski, et al.
Published: (2024-01-01)

Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme
by: Fawad Ur Rehman, et al.
Published: (2021-07-01)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
by: Aisling M. Glynn, et al.
Published: (2019-08-01)

Temozolomide-associated blepharoconjunctivitis: a case report
by: Tom Kornhauser, et al.
Published: (2024-04-01)

Glioblastoma Multiforma Tedavisinde Kanser Kök Hücrelerinin Temozolomide Karşı Oluşturdukları Direnç
by: Meryem Alagoz
Published: (2018-06-01)

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
by: Ming Chen, et al.
Published: (2023-06-01)

Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy
by: Laxmi Dhungel, et al.
Published: (2024-02-01)

Delta-radiomics Entropy Based on Tumor Heterogeneity Concept – Response Predictor to Irradiation for Unresectable/recurrent Glioblastoma
by: Camil Ciprian MIRESTEAN, et al.
Published: (2022-12-01)

A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches
by: Meijun Liu, et al.
Published: (2025-06-01)

Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide
by: Radmila Milenkovska, et al.
Published: (2025-02-01)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
by: Zijin Zhao, et al.
Published: (2021-08-01)

Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance
by: Jianlin Pu, et al.
Published: (2025-05-01)

Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy
by: Gang Ke, et al.
Published: (2025-02-01)

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01)

A Case With Multicentric Glioblastoma Multiforme
by: Elif Tolgay, et al.
Published: (2008-08-01)

Comparison of multi-cycle and standard-cycle temozolomide chemotherapies in patients with glioblastoma undergoing surgery and successive radiotherapy
by: Yuan Fu, et al.
Published: (2023-06-01)

Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
by: Evrim Metcalfe, et al.
Published: (2016-08-01)

Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance
by: Young Keun Hwang, et al.
Published: (2024-08-01)

Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation
by: Madineh Mazarei, et al.
Published: (2021-06-01)

Primary spinal glioblastoma multiforme. Single center experience and literature review
by: Milos Jokovic, et al.
Published: (2021-06-01)

Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
by: Karoline Almeida Lima, et al.
Published: (2023-04-01)

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
by: Yu-Ling Tsai, et al.
Published: (2020-09-01)

A Comparative Study of Five Target Volume Definitions for Radiotherapy in Glioblastoma Multiforme
by: Kamuran Ibis, et al.
Published: (2025-10-01)

Glioblastoma multiforme - disease overview considering sports and neurorehabilitation
by: Monika Niedźwiedzka, et al.
Published: (2024-10-01)

Primary spinal cord glioblastoma multiforme presenting with transverse myelitis
by: Melikhan Cerci, et al.
Published: (2014-06-01)

Preparation and evaluation of temozolomide loaded PLGA nanoparticles for the treatment of glioblastoma multiforme
by: Şule Şahin, et al.
Published: (2025-10-01)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
by: Makoto Ohno, et al.
Published: (2019-11-01)